A protein found in the GI tract can neutralize many bacteria
January 13, 2026
The protein, known as intelectin-2, also helps to strengthen the mucus barrier lining the digestive tract.
The protein, known as intelectin-2, also helps to strengthen the mucus barrier lining the digestive tract.
A Boston Scientific (NYSE: BSX)+
executive said on social media that the company received FDA approval for its Farapoint pulsed field ablation (PFA) catheter.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG system.
Minneapolis-based Imricor Medical Systems (ASX:IMR) said it won 510(k) clearance from the FDA for its Vision-MR Diagnostic Catheter.
SINGAPORE, Jan. 6, 2026 /PRNewswire/ — Spectrumedics Medical (hereinafter “Spectrumedics”) is pleased to announce that its Sonico-CX Intravascular Lithotripsy (IVL) System has obtained CE Mark certification under the European Union Medical Device Regulation (EU MDR). The system comprises the Sonico-CX Coronary Intravascular Lithotripsy Catheter and the Intravascular Lithotripsy Generator.
SAN JOSE, Calif., Jan. 15, 2026 /PRNewswire/ — LEADOPTIK, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Last Inch Assessment™ (LIA) system, the world’s first system to use silicon photonics imaging technology and software designed to improve the accuracy of lung biopsy procedures.
CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ — Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and Drug Administration (FDA) has approved Proliv™Rx, the first prescription, physician-directed, at-home brain neuromodulation therapy as an adjunctive treatment for adults with Major Depressive Disorder (MDD) who failed to achieve satisfactory improvement from at least one previous antidepressant medication.
Medtronic (NYSE: MDT)+
announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI).
A “unique” AI-powered headset that can predict epileptic seizures minutes before they occur has been developed by scientists in Scotland.
Researchers from Radboud University Medical Center and University of Basel have discovered new genetic causes of inherited blindness.